Overview

Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-labeled, randomization and 2x2 Cross trial to compare the pharmacokinetic effects between ketoconazole and CG100649 for healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
CrystalGenomics, Inc.
Treatments:
Ketoconazole